Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Completed
Conditions studied: Meningococcal Disease, Pregnancy, Infections, Meningococcal
In brief
The GlaxoSmithKline's Meningococcal quadrivalent CRM-197 conjugate vaccine pregnancy registry is established to meet a post marketing commitment agreed upon with CBER to prospectively collect data on pregnancy exposures to Meningococcal quadrivalent CRM-197 conjugate vaccine. It is an observational study of women inadvertently immunized with the Meningococcal quadrivalent CRM-197 conjugate vaccine within 28 days prior to conception or at any time during pregnancy as part of routine care. The objective of the pregnancy registry is to evaluate pregnancy outcomes among women immunized with the Meningococcal quadrivalent CRM-197 conjugate vaccine within 28 days prior to conception or at any time during pregnancy. The primary outcomes of interest include major congenital malformation, preterm birth, and low birth weight. Other pregnancy outcomes will be collected, including spontaneous abortions and stillbirths.
Key facts
- Study ID
- NCT02223637
- Run by
- GlaxoSmithKline
- People needed
- 93
- Starts
- 2014-09-30
- Expected to finish
- 2017-12-08
- Last updated by the study team
- 2019-06-21
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Sufficient evidence to confirm that MENVEO exposure occurred within 28 days prior to conception or at any time during pregnancy
- Sufficient information to determine whether the pregnancy is prospectively or retrospectively registered (ie, whether the outcome of pregnancy was known at the time of first contact with the registry)
- Date the pregnancy exposure is registered
- Full reporter (ie, HCP) contact information to allow for follow-up (name, address, etc.)
Where it is running
- GSK Investigational Site — Wilmington, North Carolina, United States
- GSK Investigational Site — Wilmington, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.